Compare CYTK & SNAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | SNAP |
|---|---|---|
| Founded | 1997 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 10.3B |
| IPO Year | 2004 | 2017 |
| Metric | CYTK | SNAP |
|---|---|---|
| Price | $69.27 | $5.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 26 |
| Target Price | ★ $89.26 | $8.41 |
| AVG Volume (30 Days) | 1.7M | ★ 32.7M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.71 |
| EPS | N/A | ★ N/A |
| Revenue | $13,368,000.00 | ★ $824,949,000.00 |
| Revenue This Year | $7.37 | $15.55 |
| Revenue Next Year | $310.19 | $9.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 103.95 |
| 52 Week Low | $31.99 | $3.81 |
| 52 Week High | $80.20 | $10.41 |
| Indicator | CYTK | SNAP |
|---|---|---|
| Relative Strength Index (RSI) | 45.21 | 39.04 |
| Support Level | $59.07 | $4.65 |
| Resistance Level | $70.69 | $5.52 |
| Average True Range (ATR) | 2.87 | 0.26 |
| MACD | -1.15 | -0.06 |
| Stochastic Oscillator | 25.26 | 12.97 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Snap is a technology company best known for its marquis social media application. Snapchat, a visual messaging application that has amassed hundreds of millions of users. The app was initially only used to communicate with family and friends through photographs and short videos (known as "Snaps"). Users can now enjoy augmented reality, or AR, lenses, content from famous creators and celebrities, updates about local events, and more. Although the app offers a paid subscription option with premium features, advertising sales produce most of the app's revenue. The firm also sells wearable devices called AR Spectacles, which can capture photos and videos overlayed with AR lenses, but these make up a small portion of Snap's overall sales.